Solid Bio surges after trial data for lead asset in Duchenne
Solid Biosciences (SLDB) stock surges after strong Phase 1/2 data for its Duchenne therapy SGT-003. Read more here.
Hosted on MSN7h
Bio-Techne Stock Outlook: Is Wall Street Bullish or Bearish?
Headquartered in Minneapolis, Minnesota, Bio-Techne Corporation (TECH) is a leading provider of life sciences solutions ...
Biome Australia Ltd (BIO) Gets a Buy from Bell Potter
Bell Potter analyst Martyn Jacobs maintained a Buy rating on Biome Australia Ltd (BIO – Research Report) today and set a price target of ...
Adicet Bio's SWOT analysis: gamma-delta T cell stock faces pivotal year
Adicet Bio, Inc. (NASDAQ:ACET), currently trading at $0.99 with a market capitalization of $81.7 million, is a clinical-stage biopharmaceutical company focused on developing novel cell therapies based ...
Zura Bio Limited (NASDAQ:ZURA) Receives $15.80 Consensus Target Price from Brokerages
Zura Bio Limited (NASDAQ:ZURA – Get Free Report) has earned an average recommendation of “Buy” from the seven brokerages that ...
Mustang Bio Prices Public Offering Of 2.65 Mln At $3.01/shr; Stock Down In Pre-market
Mustang Bio, Inc. (MBIO), a clinical-stage biopharmaceutical company, Thursday announced the pricing of a public offering of 2.65 ...
INmune Bio (NASDAQ:INMB) Price Target Raised to $30.00
INmune Bio (NASDAQ:INMB – Get Free Report) had its price target hoisted by investment analysts at Maxim Group from $22.00 to $30.00 in a research note issued to investors on Thursday,Benzinga reports.
True Green Bio Energy share price
Check out True Green Bio Energy share price and NSE/BSE details with 52-week high, 52-week low, Dividend, Technicals, True Green Bio Energy Quarterly Results, and more.